Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3426527
Max Phase: Preclinical
Molecular Formula: C22H33BrO4
Molecular Weight: 441.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3426527
Max Phase: Preclinical
Molecular Formula: C22H33BrO4
Molecular Weight: 441.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(O)[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OCCBr)[C@@H]2CC[C@]1(O)C3
Standard InChI: InChI=1S/C22H33BrO4/c1-14-17(24)21-9-5-15-19(2,16(21)6-10-22(14,26)13-21)7-4-8-20(15,3)18(25)27-12-11-23/h15-17,24,26H,1,4-13H2,2-3H3/t15-,16-,17?,19+,20+,21+,22-/m0/s1
Standard InChI Key: JTNZINVYUCZWES-HNYHLQPZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.41 | Molecular Weight (Monoisotopic): 440.1562 | AlogP: 3.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.80 | CX Basic pKa: | CX LogP: 3.57 | CX LogD: 3.57 |
Aromatic Rings: 0 | Heavy Atoms: 27 | QED Weighted: 0.40 | Np Likeness Score: 2.78 |
1. Lin Z, Guo Y, Gao Y, Wang S, Wang X, Xie Z, Niu H, Chang W, Liu L, Yuan H, Lou H.. (2015) ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence Probe., 58 (9): [PMID:25856683] [10.1021/acs.jmedchem.5b00208] |
Source(1):